500MBq <sup>131</sup>I administration for Basedow disease ; 4 years follow up study

Keiji Nagano

Presentation information

[JSMN]Radionuclide Therapy:Thyroid

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [JSMN]Digital Poster (Oral)

Radionuclide Therapy:Thyroid

Fri. Nov 16, 2018 10:45 AM - 11:45 AM Digital Poster (Exhibition Hall 1F Booth1)

Chair:Koichiro Abe (Department of Diagnostic Imaging and Nuclear Medicine,Tokyo Women's Medical University)

[M2B1B3] 500MBq ¹³¹I administration for Basedow disease ; 4 years follow up study

Keiji Nagano¹, Yasushi Itagaki¹, Go Takai¹, Susumu Kubota¹, Yuka Tsukamoto², Tetsuya Kimura², Yasuyuki Okamoto² (1.Department of Therapeutic Radiology, Kansai Electric Power Hospital, Osaka, Japan, 2.Okamoto Thyroid Clinic , Osaka, Japan)

Abstract password authentication.
You can find the password in the Program ("Information for Paticipants").

« Previous in this session
Next in this session »

▲

Presentation information

Radionuclide Therapy:Thyroid

[M2B1B3] 500MBq 131I administration for Basedow disease ; 4 years follow up study

Password

[M2B1B3] 500MBq ¹³¹I administration for Basedow disease ; 4 years follow up study